We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ANGPT2/TIE2: Attractive Targets for Improved Anti-angiogenic Cancer Therapy
Product
Advertisement

ANGPT2/TIE2: Attractive Targets for Improved Anti-angiogenic Cancer Therapy

ANGPT2/TIE2: Attractive Targets for Improved Anti-angiogenic Cancer Therapy
Product
Advertisement

ANGPT2/TIE2: Attractive Targets for Improved Anti-angiogenic Cancer Therapy

Angiopoietin-2 (ANGPT2) is a ligand of the receptor tyrosine kinase TIE2 (TEK). In conjunction with vascular endothelial growth factor (VEGF), ANGPT2-TIE2 signaling induces vascular sprouting. Inhibition of ANGPT2 shows promising results in preventing tumor angiogenesis, tumor growth, and metastasis in preclinical models, making it an attractive candidate to target in cancer.

ANGPT2 is highly upregulated at the early stages of tumor progression to drive neovessel formation. Conventional anti-VEGF therapies primarily target immature blood vessels in tumors. The combinational targeting of both ANGPT2 and VEGF pathways is now expected to improve clinical efficacy by expanding the target vessel population. Sino Biological has developed high-quality reagents to support the study of the ANGPT2/TIE2 signaling.

ANGPT2/TIE2 Pathway Proteins
ANGPT2/TIE2 Pathway Antibodies


Company Details
Sino Biological Inc
1400 Liberty Ridge Drive
Suite 101
Wayne
PA
19087
United States
Tel: +1-215-583-7898
Fax: +1-267-657-0217
Advertisement